April

Major conceptual change required to improve lung cancer: see a respiratory physician Field J.K., Brambilla C. Eur Respir J 2003; 21: 565-566
In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma Jones H.A., Marino P.S., Shakur B.H., Morrell N.W. Eur Respir J 2003; 21: 567-573
Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-β kinase pathway Escotte S., Tabary O., Dusser D., Majer-Teboul C., Puchelle E., Jacquot J. Eur Respir J 2003; 21: 574-581
Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis Gibson P.G., Wark P.A.B., Simpson J.L., Meldrum C., Meldrum S., Saltos N., Boyle M. Eur Respir J 2003; 21: 582-588
Increased inflammatory markers in the exhaled breath condensate of cigarette smokers Carpagnano G.E., Kharitonov S.A., Foschino-Barbaro M.P., Resta O., Gramiccioni E., Barnes P.J. Eur Respir J 2003; 21: 589-593
Exhaled NO and plasma cGMP increase after endotoxin infusion in healthy volunteers Soop A., Sollevi A., Weitzberg E., Lundberg J.O.N., Palm J., Albert J. Eur Respir J 2003; 21: 594-599
Biological markers in nasal secretions Riechelmann H., Deutschle T., Friemel E., Gross H-J., Bachem M. Eur Respir J 2003; 21: 600-605
Lung cancer: the importance of seeing a respiratory physician Fergusson R.J., Thomson C.S., Brewster D.H., Brown P.H., Milroy R., on behalf of the ... Eur Respir J 2003; 21: 606-610
Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions Meert A-P., Verdebout J-M., Martin B., Ninane V., Feoli F., Sculier J-P. Eur Respir J 2003; 21: 611-615
Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children Leung T.F., Wong C.K., Lam C.W.K., Li A.M., Ip W.K., Wong G.W.K., Fok T.F. Eur Respir J 2003; 21: 616-620
Wheeze monitoring in children for assessment of nocturnal asthma and response to therapy Bentur L., Beck R., Shinawi M., Naveh T., Gavriely N. Eur Respir J 2003; 21: 621-626
Effect of intravenous hydrocortisone on nocturnal airflow limitation in childhood asthma Landstra A.M., Boezen H.M., Postma D.S., van Aalderen W.M.C. Eur Respir J 2003; 21: 627-632
Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma Sim D., Griffiths A., Armstrong D., Clarke C., Rodda C., Freezer N. Eur Respir J 2003; 21: 633-636
Long-term follow-up of toluene diisocyanate-induced asthma Padoan M., Pozzato V., Simoni M., Zedda L., Milan G., Bononi I., Piola C., Maestrelli P., Boschetto P., Mapp C.E. Eur Respir J 2003; 21: 637-640
Airway inflammation in waste handlers exposed to bioaerosols assessed by induced sputum Heldal K.K., Halstensen A.S., Thorn J., Eduard W., Halstensen T.S. Eur Respir J 2003; 21: 641-645
Lung accumulations of eosinophil granulocytes after exposure to cornstarch glove powder Grunewald J., Eklund A., Katchar K., Moshfegh A., Liden C., Lundgren L., Skare L., Tornling G. Eur Respir J 2003; 21: 646-651
Chlorine inhalation produces nasal congestion in allergic rhinitics without mast cell degranulation Shusterman D., Balmes J., Avila P.C., Murphy M.A., Matovinovic E. Eur Respir J 2003; 21: 652-657
Relationship between FEV1 reduction and respiratory symptoms in the general population Jakeways N., McKeever T., Lewis S.A., Weiss S.T., Britton J. Eur Respir J 2003; 21: 658-663
Nutrition and respiratory health in adults: findings from the Health Survey for Scotland Kelly Y., Sacker A., Marmot M. Eur Respir J 2003; 21: 664-671
Passive smoking and respiratory symptoms in the FinEsS Study Larsson M.L., Loit H-M., Meren M., Polluste J., Magnusson A., Larsson K., Lundback B. Eur Respir J 2003; 21: 672-676
Replacement of physiologically autoinhaled nitric oxide in intubated patients Rohrig L., Kuhlen R., Baumert J., Rossaint R. Eur Respir J 2003; 21: 677-681
Determinants of altered quality of life in patients with sleep-related breathing disorders Sforza E., Janssens J.P., Rochat T., Ibanez V. Eur Respir J 2003; 21: 682-687
The role of mean inspiratory effort on daytime sleepiness Pelin Z., Karadeniz D., Ozturk L., Gozukirmizi E., Kaynak H. Eur Respir J 2003; 21: 688-694
A prediction rule to identify allocation of inpatient care in community-acquired pneumonia Espana P.P., Capelastegui A., Quintana J.M., Soto A., Gorordo I., Garcia-Urbaneja M., Bilbao A. Eur Respir J 2003; 21: 695-701
C-reactive protein levels in community-acquired pneumonia Garcia Vazquez E., Martinez J.A., Mensa J., Sanchez F., Marcos M.A., de Roux A., Torres A. Eur Respir J 2003; 21: 702-705
Definitions and types of work-related asthma: a nosological approach Vandenplas O., Malo J-L. Eur Respir J 2003; 21: 706-712
Coxiella burnetii pneumonia Marrie T.J. Eur Respir J 2003; 21: 713-719
Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome Moloney E.D., Evans T.W. Eur Respir J 2003; 21: 720-727
Progressive dyspnoea in a 40-yr-old female Ghekiere O., Weynand B., Collard P., Coche E. Eur Respir J 2003; 21: 728-731
The best treatment for the first episode of primary spontaneous pneumothorax: an unanswered question Pieters T. Eur Respir J 2003; 21: 732
From the Authors Tschopp J-M., Boutin C., Astoul P., Janssen J-P., Bolliger C-T., Delaunois L., Driesen P., Tassi G., Perruchoud A-P., the European Stud... Eur Respir J 2003; 21: 732-733
Carbon dioxide production during acetazolamide and medroxyprogesterone treatment Cole R.P. Eur Respir J 2003; 21: 733
From the Authors Wagenaar M., Folgering H. Eur Respir J 2003; 21: 733
Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study. T.M.L. Eagan, P.S. Bakke, G.E. Eide, A. Gulsvik. Eur Respir J 2003; 21: 735